These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 9572539)
21. Nonsteroidal eye drops for ocular allergy. Schwab IR West J Med; 1994 Dec; 161(6):594-5. PubMed ID: 7856163 [No Abstract] [Full Text] [Related]
22. A double-blind evaluation of the analgesic efficacy and toxicity of oral ketorolac and diclofenac in cancer pain. The TD/10 recordati Protocol Study Group. Pannuti F; Robustelli della Cuna G; Ventaffrida V; Strocchi E; Camaggi CM Tumori; 1999; 85(2):96-100. PubMed ID: 10363074 [TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of nonpreserved ketorolac ophthalmic solution in postoperative ocular pain following radial keratotomy. Brint SF; Cheetham JK; DeGryse R; Abel ML; Thompson VM; Rosenthal A J Cataract Refract Surg; 1999 Jan; 25(1):41-9. PubMed ID: 9888075 [TBL] [Abstract][Full Text] [Related]
24. A double-blind study comparing two single-dose regimens of ketorolac with diclofenac in pain due to cancer. Minotti V; Betti M; Ciccarese G; Fumi G; Tonato M; Del Favero A Pharmacotherapy; 1998; 18(3):504-8. PubMed ID: 9620101 [TBL] [Abstract][Full Text] [Related]
25. Analgesic efficacy and safety of nonpreserved ketorolac tromethamine ophthalmic solution following radial keratotomy. Ketorolac Radial Keratotomy Study Group. Yee RW Am J Ophthalmol; 1998 Apr; 125(4):472-80. PubMed ID: 9559732 [TBL] [Abstract][Full Text] [Related]
26. A randomized, double-masked, placebo-controlled parallel study of loteprednol etabonate 0.2% in patients with seasonal allergic conjunctivitis. Shulman DG; Lothringer LL; Rubin JM; Briggs RB; Howes J; Novack GD; Hart K Ophthalmology; 1999 Feb; 106(2):362-9. PubMed ID: 9951491 [TBL] [Abstract][Full Text] [Related]
27. Comparison of the effects of ketotifen fumarate 0.025% and olopatadine HCl 0.1% ophthalmic solutions in seasonal allergic conjunctivities: a 30-day, randomized, double-masked, artificial tear substitute-controlled trial. Avunduk AM; Tekelioglu Y; Turk A; Akyol N Clin Ther; 2005 Sep; 27(9):1392-402. PubMed ID: 16291412 [TBL] [Abstract][Full Text] [Related]
28. A critical look at ocular allergy drugs. Joseph Titi M Am Fam Physician; 1996 Jun; 53(8):2637-42, 2645-6. PubMed ID: 8644576 [TBL] [Abstract][Full Text] [Related]
29. Ketorolac: a new antiinflammatory for seasonal allergic conjunctivitis. Holdcroft C Nurse Pract; 1994 May; 19(5):30. PubMed ID: 8065646 [No Abstract] [Full Text] [Related]
30. Comparison of the topical ocular antiallergic efficacy of emedastine 0.05% ophthalmic solution to ketorolac 0.5% ophthalmic solution in a clinical model of allergic conjunctivitis. Discepola M; Deschenes J; Abelson M Acta Ophthalmol Scand Suppl; 1999; (228):43-6. PubMed ID: 10337432 [TBL] [Abstract][Full Text] [Related]